Literature DB >> 23369136

Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.

A Dei Cas1, V Spigoni, V Ridolfi, M Metra.   

Abstract

Diabetes and chronic heart failure are interrelated conditions with major medical and economic impact that have to be treated as a distinct entity. Several pathological mechanisms have been investigated and proposed to explain the structural and functional changes associated with diabetic cardiomyopathy. These mechanisms are likely to act synergically and may potentiate one the other. This review outlines recent advances in the pathophysiological mechanisms implicated in the development and progression of diabetic cardiomyopathy and in current therapeutic strategies.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23369136     DOI： 10.2174/1871530311313010006

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN： 1871-5303            Impact factor:   2.895


  11 in total

Review 1.  Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.

Authors:  Rasha Mofeed Habeeb Mosa; Zhen Zhang; Renfu Shao; Chao Deng; Jiezhong Chen; Chen Chen
Journal:  Endocrine       Date:  2015-02-04       Impact factor: 3.633

2.  Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients.

Authors:  P Ruscitti; P Cipriani; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; F Ciccia; S Alvaro; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-07-19       Impact factor: 4.330

Review 3.  Novel insight into the dangerous connection between diabetes and heart failure.

Authors:  C Lombardi; V Spigoni; E Gorga; A Dei Cas
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

Review 4.  Updating experimental models of diabetic cardiomyopathy.

Authors:  J Fuentes-Antrás; B Picatoste; A Gómez-Hernández; J Egido; J Tuñón; Ó Lorenzo
Journal:  J Diabetes Res       Date:  2015-04-20       Impact factor: 4.011

5.  Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study.

Authors:  Julio A Chirinos; Abigail Khan; Nisha Bansal; Daniel L Dries; Harold I Feldman; Virginia Ford; Amanda H Anderson; Radhakrishna Kallem; James P Lash; Akinlolu Ojo; Martin Schreiber; Angela Sheridan; Jillian Strelsin; Valerie Teal; Jason Roy; Qiang Pan; Alan S Go; Raymond R Townsend
Journal:  Circ Heart Fail       Date:  2014-07-24       Impact factor: 8.790

6.  Cardiac fibrosis and down regulation of GLUT4 in experimental diabetic cardiomyopathy are ameliorated by chronic exposures to intermittent altitude.

Authors:  Mahdi Faramoushi; Ramin Amir Sasan; Vahid Sari Sarraf; Pouran Karimi
Journal:  J Cardiovasc Thorac Res       Date:  2016-03-14

Review 7.  Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives.

Authors:  Luis E León; Sweta Rani; Mauricio Fernandez; Martín Larico; Sebastián D Calligaris
Journal:  J Diabetes Res       Date:  2015-12-06       Impact factor: 4.011

Review 8.  Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis.

Authors:  Meng-Die Chen; Si-Si Dong; Ning-Yu Cai; Meng-Di Fan; Su-Ping Gu; Jin-Jue Zheng; Hai-Min Yin; Xin-He Zhou; Liang-Xue Wang; Chun-Ying Li; Chao Zheng
Journal:  BMC Cardiovasc Disord       Date:  2016-01-29       Impact factor: 2.298

Review 9.  Metabolic Effects of Metformin in the Failing Heart.

Authors:  Aleksandra Dziubak; Grażyna Wójcicka; Andrzej Wojtak; Jerzy Bełtowski
Journal:  Int J Mol Sci       Date:  2018-09-21       Impact factor: 5.923

10.  Self-care education program improves quality of life in patients with chronic heart failure: A randomized controlled study protocol.

Authors:  Jing Wang; Weiwei Li
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.